Compare CADL & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | RWT |
|---|---|---|
| Founded | 1999 | 1994 |
| Country | United States | United States |
| Employees | 55 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 739.2M | 597.9M |
| IPO Year | 2021 | 1996 |
| Metric | CADL | RWT |
|---|---|---|
| Price | $9.92 | $3.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $21.75 | $5.52 |
| AVG Volume (30 Days) | 1.1M | ★ 8.2M |
| Earning Date | 11-12-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 21.62% |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.35 | $3.22 |
| 52 Week High | $14.00 | $6.97 |
| Indicator | CADL | RWT |
|---|---|---|
| Relative Strength Index (RSI) | 36.74 | 25.76 |
| Support Level | $9.18 | N/A |
| Resistance Level | $10.59 | $5.36 |
| Average True Range (ATR) | 0.56 | 0.14 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 15.26 | 0.13 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.